Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care.

Oreja-Guevara C, Potra S, Bauer B, Centonze D, Giambastiani MP, Giovannoni G, Kesselring J, Langdon D, Morrow SA, Nouvet-Gire J, Pontaga M, Rieckmann P, Schippling S, Alexandri N, Shanahan J, Thompson H, Van Galen P, Vermersch P, Yeandle D.

Adv Ther. 2019 Nov;36(11):3238-3252. doi: 10.1007/s12325-019-01071-9. Epub 2019 Sep 5.

PMID:
31487006
2.

Experiences of Low Mood in Young People With Cancer: A Qualitative Study.

Reed-Berendt R, Shafran R, Langdon D, Christie D, Hough R, Coughtrey A.

J Pediatr Oncol Nurs. 2019 Nov/Dec;36(6):424-435. doi: 10.1177/1043454219844232. Epub 2019 May 8.

PMID:
31068048
3.

Usability of Health Information Websites Designed for Adolescents: Systematic Review, Neurodevelopmental Model, and Design Brief.

Reen GK, Muirhead L, Langdon DW.

J Med Internet Res. 2019 Apr 23;21(4):e11584. doi: 10.2196/11584. Review.

4.

Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.

Joisten N, Rademacher A, Bloch W, Schenk A, Oberste M, Dalgas U, Langdon D, Caminada D, Purde MT, Gonzenbach R, Kool J, Zimmer P, Bansi J.

BMC Neurol. 2019 Mar 8;19(1):37. doi: 10.1186/s12883-019-1267-9.

5.

A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study.

Bove RM, Rush G, Zhao C, Rowles W, Garcha P, Morrissey J, Schembri A, Alailima T, Langdon D, Possin K, Gazzaley A, Feinstein A, Anguera J.

Neurol Ther. 2019 Jun;8(1):135-145. doi: 10.1007/s40120-018-0121-0. Epub 2018 Nov 30.

6.

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier.

Yeandle D, Rieckmann P, Giovannoni G, Alexandri N, Langdon D.

Neurol Ther. 2018 Dec;7(2):179-187. doi: 10.1007/s40120-018-0118-8. Epub 2018 Nov 9.

7.

Cognitive rehabilitation, self-management, psychotherapeutic and caregiver support interventions in progressive neurodegenerative conditions: A scoping review.

Clare L, Teale JC, Toms G, Kudlicka A, Evans I, Abrahams S, Goldstein LH, Hindle JV, Ho AK, Jahanshahi M, Langdon D, Morris R, Snowden JS, Davies R, Markova I, Busse M, Thompson-Coon J.

NeuroRehabilitation. 2018;43(4):443-471. doi: 10.3233/NRE-172353.

PMID:
30412509
8.

Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in the Portuguese population with multiple sclerosis.

Sousa C, Rigueiro-Neves M, Miranda T, Alegria P, Vale J, Passos AM, Langdon D, Sá MJ.

BMC Neurol. 2018 Oct 17;18(1):172. doi: 10.1186/s12883-018-1175-4.

9.

Learning ability correlates with brain atrophy and disability progression in RRMS.

Sormani MP, De Stefano N, Giovannoni G, Langdon D, Piani-Meier D, Haering DA, Kappos L, Tomic D.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):38-43. doi: 10.1136/jnnp-2018-319129. Epub 2018 Oct 15.

10.

Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study.

Bakirtzis C, Konstantinopoulou E, Langdon DW, Grigoriadou E, Minti F, Nikolaidis I, Boziki MK, Tatsi T, Ioannidis P, Karapanayiotides T, Afrantou T, Hadjigeorgiou G, Grigoriadis N.

J Neurol Sci. 2018 Dec 15;395:106-112. doi: 10.1016/j.jns.2018.10.004. Epub 2018 Oct 4.

PMID:
30308444
11.

How does cognition relate to employment in multiple sclerosis? A systematic review.

Clemens L, Langdon D.

Mult Scler Relat Disord. 2018 Nov;26:183-191. doi: 10.1016/j.msard.2018.09.018. Epub 2018 Sep 15.

PMID:
30268039
12.

Should whole body cryotherapy sessions be differentiated between women and men? A preliminary study on the role of the body thermal resistance.

Polidori G, Cuttell S, Hammond L, Langdon D, Legrand F, Taiar R, Boyer FC, Costello JT.

Med Hypotheses. 2018 Nov;120:60-64. doi: 10.1016/j.mehy.2018.08.017. Epub 2018 Aug 24.

PMID:
30220342
13.

Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple Sclerosis.

Reen GK, Silber E, Langdon DW.

Value Health. 2018 Jul;21(7):762-766. doi: 10.1016/j.jval.2017.12.015. Epub 2018 Feb 9.

14.

A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS).

Corfield F, Langdon D.

Neurol Ther. 2018 Dec;7(2):287-306. doi: 10.1007/s40120-018-0102-3. Epub 2018 Jun 19. Review.

15.

Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.

Goodin DS, Reder AT, Traboulsee AL, Li DK, Langdon D, Cutter G, Cook S, O'Donnell T, Kremenchutzky M, Oger J, Koelbach R, Pohl C, Wicklein EM; IFNB Multiple Sclerosis Study Group and the 16- and 21-Year LTF Investigators.

Mult Scler. 2019 May;25(6):837-847. doi: 10.1177/1352458518773511. Epub 2018 May 15.

PMID:
29761737
16.

The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: The case of multiple sclerosis.

Kobelt G, Langdon D, Jönsson L.

Mult Scler. 2019 Apr;25(5):740-749. doi: 10.1177/1352458518769837. Epub 2018 Apr 17.

17.

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T; MAGNIMS study group.

Neurosci Biobehav Rev. 2018 Jun;89:85-98. doi: 10.1016/j.neubiorev.2018.02.012. Epub 2018 Feb 23. Review.

PMID:
29477616
18.

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan.

Niino M, Fukazawa T, Kira JI, Okuno T, Mori M, Sanjo N, Ohashi T, Fukaura H, Fujimori J, Shimizu Y, Mifune N, Miyazaki Y, Takahashi E, Kikuchi S, Langdon D, Hb Benedict R, Matsui M.

Mult Scler J Exp Transl Clin. 2017 Dec 26;3(4):2055217317748972. doi: 10.1177/2055217317748972. eCollection 2017 Oct-Dec.

19.

Congenital Hyperinsulinism and Hypopituitarism Attributable to a Mutation in FOXA2.

Vajravelu ME, Chai J, Krock B, Baker S, Langdon D, Alter C, De León DD.

J Clin Endocrinol Metab. 2018 Mar 1;103(3):1042-1047. doi: 10.1210/jc.2017-02157.

20.

Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.

Members of the MS in the 21st Century Steering Group:, Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J, Kobelt G, Langdon D, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P, Aston K, Bauer B, Demory C, Giambastiani MP, Hlavacova J, Nouvet-Gire J, Pepper G, Pontaga M, Rogan E, Rogalski C, van Galen P, Ben-Amor AF.

Mult Scler Relat Disord. 2018 Jan;19:153-160. doi: 10.1016/j.msard.2017.11.013. Epub 2017 Nov 21.

21.

Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.

Bansi J, Koliamitra C, Bloch W, Joisten N, Schenk A, Watson M, Kool J, Langdon D, Dalgas U, Kesselring J, Zimmer P.

J Neuroimmunol. 2018 Jan 15;314:101-105. doi: 10.1016/j.jneuroim.2017.12.001. Epub 2017 Dec 6.

PMID:
29224960
22.

Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study.

Costers L, Gielen J, Eelen PL, Schependom JV, Laton J, Remoortel AV, Vanzeir E, Wijmeersch BV, Seeldrayers P, Haelewyck MC, D'Haeseleer M, D'hooghe MB, Langdon D, Nagels G.

Mult Scler Relat Disord. 2017 Nov;18:33-40. doi: 10.1016/j.msard.2017.08.018. Epub 2017 Sep 7.

PMID:
29141818
23.

Development of a youth-report measure of DPN symptoms: Conceptualization and content validation.

Moser J, Lipman T, Langdon DR, Bevans KB.

J Clin Transl Endocrinol. 2017 Jul 8;9:55-60. doi: 10.1016/j.jcte.2017.07.001. eCollection 2017 Sep.

24.

High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial.

Zimmer P, Bloch W, Schenk A, Oberste M, Riedel S, Kool J, Langdon D, Dalgas U, Kesselring J, Bansi J.

Mult Scler. 2018 Oct;24(12):1635-1644. doi: 10.1177/1352458517728342. Epub 2017 Aug 21.

PMID:
28825348
25.

Influence of nationality on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

Smerbeck A, Benedict RHB, Eshaghi A, Vanotti S, Spedo C, Blahova Dusankova J, Sahraian MA, Marques VD, Langdon D.

Clin Neuropsychol. 2018 Jan;32(1):54-62. doi: 10.1080/13854046.2017.1354071. Epub 2017 Jul 19.

PMID:
28721748
26.

Individualising the exposure of -110°C whole body cryotherapy: The effects of sex and body composition.

Cuttell S, Hammond L, Langdon D, Costello J.

J Therm Biol. 2017 Apr;65:41-47. doi: 10.1016/j.jtherbio.2017.01.014. Epub 2017 Jan 27.

PMID:
28343574
27.

Functional training is a senseless strategy in MS cognitive rehabilitation: Strategy training is the only useful approach - NO.

Hulst HE, Langdon DW.

Mult Scler. 2017 Jun;23(7):930-932. doi: 10.1177/1352458517692422. Epub 2017 Mar 23. No abstract available.

28.

Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing.

Charvet LE, Shaw M, Frontario A, Langdon D, Krupp LB.

Mult Scler. 2018 Apr;24(4):512-519. doi: 10.1177/1352458517701588. Epub 2017 Mar 21.

PMID:
28322606
29.

Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review.

Reen GK, Silber E, Langdon DW.

J Neurol Sci. 2017 Apr 15;375:107-122. doi: 10.1016/j.jns.2016.12.038. Epub 2016 Dec 23. Review.

PMID:
28320112
30.

A Randomised Controlled Trial of Efficacy of Cognitive Rehabilitation in Multiple Sclerosis: A Cognitive, Behavioural, and MRI Study.

Campbell J, Langdon D, Cercignani M, Rashid W.

Neural Plast. 2016;2016:4292585. doi: 10.1155/2016/4292585. Epub 2016 Dec 27.

31.

Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic review.

Reen GK, Silber E, Langdon DW.

Patient Educ Couns. 2017 Jun;100(6):1031-1048. doi: 10.1016/j.pec.2016.12.028. Epub 2016 Dec 28. Review.

PMID:
28108125
32.

The contribution of short-term memory capacity to reading ability in adolescents with cochlear implants.

Edwards L, Aitkenhead L, Langdon D.

Int J Pediatr Otorhinolaryngol. 2016 Nov;90:37-42. doi: 10.1016/j.ijporl.2016.08.017. Epub 2016 Aug 26.

PMID:
27729149
33.

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.

Polychroniadou E, Bakirtzis C, Langdon D, Lagoudaki R, Kesidou E, Theotokis P, Tsalikakis D, Poulatsidou K, Kyriazis O, Boziki M, Papadopoulos G, Boura E, Sintila L, Hatzigeorgiou S, Ziamos C, Ioannidis P, Karacostas D, Grigoriadis N.

Mult Scler Relat Disord. 2016 Sep;9:68-72. doi: 10.1016/j.msard.2016.06.011. Epub 2016 Jun 28.

PMID:
27645348
34.

Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.

Campbell J, Rashid W, Cercignani M, Langdon D.

Postgrad Med J. 2017 Mar;93(1097):143-147. doi: 10.1136/postgradmedj-2016-134071. Epub 2016 Aug 10.

PMID:
27512050
35.

A useful annual review of cognition in relapsing MS is beyond most neurologists - NO.

Langdon D.

Mult Scler. 2016 May;22(6):728-30. doi: 10.1177/1352458516640610. Epub 2016 Apr 5. No abstract available.

PMID:
27048311
36.

Cognitive assessment in MS.

Langdon D.

Neurodegener Dis Manag. 2015;5(6 Suppl):43-5. doi: 10.2217/nmt.15.62. Review. No abstract available.

PMID:
26611272
37.

A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).

O'Connell K, Langdon D, Tubridy N, Hutchinson M, McGuigan C.

Mult Scler Relat Disord. 2015 Nov;4(6):521-5. doi: 10.1016/j.msard.2015.07.012. Epub 2015 Aug 7.

PMID:
26590658
38.

The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.

Sandi D, Rudisch T, Füvesi J, Fricska-Nagy Z, Huszka H, Biernacki T, Langdon DW, Langane É, Vécsei L, Bencsik K.

Mult Scler Relat Disord. 2015 Nov;4(6):499-504. doi: 10.1016/j.msard.2015.07.006. Epub 2015 Jul 8.

PMID:
26590654
39.

Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.

Bove R, White CC, Giovannoni G, Glanz B, Golubchikov V, Hujol J, Jennings C, Langdon D, Lee M, Legedza A, Paskavitz J, Prasad S, Richert J, Robbins A, Roberts S, Weiner H, Ramachandran R, Botfield M, De Jager PL.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e162. doi: 10.1212/NXI.0000000000000162. eCollection 2015 Dec.

40.

Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group.

Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, LeLorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P.

Mult Scler Relat Disord. 2015 May;4(3):202-18. doi: 10.1016/j.msard.2015.02.005. Epub 2015 Mar 2. Review.

41.

The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population.

Goretti B, Niccolai C, Hakiki B, Sturchio A, Falautano M, Minacapelli E, Martinelli V, Incerti C, Nocentini U, Murgia M, Fenu G, Cocco E, Marrosu MG, Garofalo E, Ambra FI, Maddestra M, Consalvo M, Viterbo RG, Trojano M, Losignore NA, Zimatore GB, Pietrolongo E, Lugaresi A, Langdon D, Portaccio E, Amato MP.

BMC Neurol. 2014 Sep 10;14:171. doi: 10.1186/s12883-014-0171-6.

42.

Assessment of the ergogenic effect of caffeine supplementation on mood, anticipation timing, and muscular strength in older adults.

Tallis J, Duncan MJ, Wright SL, Eyre EL, Bryant E, Langdon D, James RS.

Physiol Rep. 2013 Aug;1(3):e00072. doi: 10.1002/phy2.72. Epub 2013 Aug 29.

43.

The effect of acute caffeine ingestion on coincidence anticipation timing in younger and older adults.

Duncan MJ, Tallis J, Wright SL, Eyre EL, Bryant E, Langdon D.

Nutr Neurosci. 2014 Sep;17(5):234-8. doi: 10.1179/1476830513Y.0000000093. Epub 2013 Nov 26.

PMID:
24192642
44.

Triple dissociation of attention networks in stroke according to lesion location.

Rinne P, Hassan M, Goniotakis D, Chohan K, Sharma P, Langdon D, Soto D, Bentley P.

Neurology. 2013 Aug 27;81(9):812-20. doi: 10.1212/WNL.0b013e3182a2ca34. Epub 2013 Jul 31.

45.

Diabetic peripheral neuropathy in youth.

Moser JT, Langdon DR.

J Pediatr Nurs. 2013 Jul-Aug;28(4):415-7. doi: 10.1016/j.pedn.2013.04.001. Epub 2013 May 4. No abstract available.

PMID:
23648009
46.

Racial disparities in screening for diabetic retinopathy in youth with type 1 diabetes.

Dumser SM, Ratcliffe SJ, Langdon DR, Murphy KM, Lipman TH.

Diabetes Res Clin Pract. 2013 Jul;101(1):e3-5. doi: 10.1016/j.diabres.2013.03.009. Epub 2013 May 1.

PMID:
23642967
47.

Reports of patients and relatives from the CogniCIS study about cognition in clinically isolated syndrome: what are our patients telling us?

Langdon DW, Benedict RH, Wicklein EM, Beckmann K, Fredrikson S.

Eur Neurol. 2013;69(6):346-51. doi: 10.1159/000345698. Epub 2013 Apr 26.

PMID:
23635720
48.

The evaluation of peripheral neuropathy in youth with type 1 diabetes.

Moser JT, Langdon DR, Finkel RS, Ratcliffe SJ, Foley LR, Andrews-Rearson ML, Murphy KM, Lipman TH.

Diabetes Res Clin Pract. 2013 Apr;100(1):e3-6. doi: 10.1016/j.diabres.2013.01.015. Epub 2013 Feb 5.

PMID:
23391743
49.

50 years ago in the Journal of Pediatrics: female adrenogenital syndrome: early surgical repair.

Stanescu DE, Langdon DR.

J Pediatr. 2013 Jan;162(1):61. doi: 10.1016/j.jpeds.2012.08.007. No abstract available.

PMID:
23260311
50.

Treatment of cognitive impairment in multiple sclerosis: position paper.

Amato MP, Langdon D, Montalban X, Benedict RH, DeLuca J, Krupp LB, Thompson AJ, Comi G.

J Neurol. 2013 Jun;260(6):1452-68. doi: 10.1007/s00415-012-6678-0. Epub 2012 Nov 23. Review.

PMID:
23180174

Supplemental Content

Loading ...
Support Center